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Pancreatic Noradrenergic Nerves Are Activated by Neuroglucopenia
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Evidence for Stress-specific and Regionally Selective Activation of the Sympathetic Nervous System
Peter J. Havel, Richard C. Veith, Beth E. Dunning, and Gerald J. Taborsky, Jr.
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Abstract
To determine if acute stress activates pancreatic noradrenergic
nerves, pancreatic norepinephrine (NE) output (spillover) was
measured in halothane-anesthetized dogs. Central neurogluco-
penia, induced by intravenous 2-deoxy-D-glucose (12-DGJ 600
mg/kg + 13.5 mg/kg-' per min') increased pancreatic NE
output from a baseline of 380±100 to 1,490±340 pg/min (A
= +1,110±290 pg/min, P < 0.01). Surgical denervation of the
pancreas reduced this response by 90% (A = +120±50 pg/
min, P < 0.01 vs. intact innervation), suggesting that 2-DG
activated pancreatic nerves by increasing the central sympa-
thetic outflow to the pancreas rather than by acting directly on
nerves within the pancreas itself. These experiments provide
the first direct evidence of stress-induced activation of pancre-
atic noradrenergic nerves in vivo. In contrast, neither hemor-
rhagic hypotension (50 mmHg) nor hypoxia (6-8% 02) in-
creased pancreatic NE output (A = +80±110 and -20±60
pg/min, respectively, P < 0.01 vs. neuroglucopenia) despite
both producing increases of arterial plasma NE and epineph-
rine similar to glucopenia. The activation of pancreatic norad-
renergic nerves is thus stress specific. Furthermore, because
both glucopenia and hypotension increased arterial NE, yet
only glucopenia activated pancreatic nerves, it is suggested
that a regionally selective pattern of sympathetic activation can
be elicited by acute stress, a condition in which sympathetic
activation has traditionally been thought to be generalized and
nondiscrete.
Introduction
The presence of noradrenergic nerves in the pancreatic islets
has been well documented (1, 2). The physiological impor-
tance of this noradrenergic input has been inferred from ob-
servations that electrical stimulation of sympathetic nerves in-
hibits insulin secretion (3, 4) and stimulates glucagon secretion
(4, 5) and that similar patterns of islet hormone secretion occur
during sympathoadrenal activation induced by acute stress (6).
Despite such inferential evidence, there has been no direct
demonstration that pancreatic noradrenergic nerves are, in
fact, activated by acute stress.
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A number of methods have been developed to assess nor-
adrenergic activity in individual organs, the most direct being
the measurement of local norepinephrine (NE)' spillover into
an organ's venous effluent. However, because significant
quantities of NE arrive via the arterial circulation, accurate
assessment of net organ spillover requires knowledge of the
extraction of arterial NE by that organ.
We have previously developed a method to measure pan-
creatic NE extraction (7), and thus pancreatic NE spillover. In
this study, we first sought to validate this technique by mea-
suring pancreatic NE output (spillover) before, during, and
after direct activation of pancreatic noradrenergic nerves. To
produce known activation, we electrically stimulated the tho-
racic splanchnic nerves of halothane-anesthetized dogs. As a
further validation, we repeated the stimulations in dogs whose
pancreata had been surgically denervated.
Next, to determine if acute stress activates pancreatic nor-
adrenergic nerves, we measured pancreatic NE spillover dur-
ing three types of stress known to produce sympathoadrenal
activation: neuroglucopenia induced by the intravenous ad-
ministration of 2-deoxy-D-glucose (2-DG) (8), hypotension in-
duced by hemorrhage, and hypoxia induced by the partial
replacement of inspired oxygen with nitrogen, all in halo-
thane-anesthetized dogs. To assess the magnitude of the sys-
temic sympathoadrenal activation produced by these stresses,
we also measured arterial NE and epinephrine (EPI) levels
before and during each stress.
To determine if the activation of pancreatic noradrenergic
nerves during neuroglucopenia was due to increased sympa-
thetic outflow to the pancreas, or to a direct effect of 2-DG on
nerves within the pancreas itself, 2-DG was administered to
dogs with surgically denervated pancreata. 2-DG also was in-
fused directly into the superior pancreatic artery of dogs with
intact pancreatic innervation. To address further whether the
activation of pancreatic noradrenergic nerves is centrally me-
diated, a local glucopenia of the central nervous system was
produced by administration of2-DG and another glucopenia-
inducing glucose analogue, 5-thioglucose (5-TG), into the lat-
eral cerebral ventricles of halothane-anesthetized dogs.
Finally, to verify that increases of arterial plasma NE were
because of the activation of systemic sympathetic nerves,
rather than the release ofNE from the adrenal medulla, as has
been suggested (9, 10), the glucopenia and hypotension exper-
iments were repeated in adrenal-deprived dogs.
1. Abbreviations used in this paper: BTSNS, bilateral thoracic splanch-
nic nerve stimulation; EPI, epinephrine; FA, femoral artery; 5-TG,
5-thioglucose; HR, heart rate; MAP, mean arterial pressure; NE, nor-
epinephrine; SPV, superior pancreatic vein; 2-DG, 2-deoxyglucose.
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Methods
Animals and surgical procedures. After an overnight fast (- 18 h),
adult dogs of mixed breed (25-40 kg) were anesthetized with the ultra-
shortacting barbiturate, thiamylal sodium (Surital; Parke, Davis & Co.,
Morris Plains, NJ). Anesthesia was subsequently maintained with
halothane (0.8%) administered from a calibrated vaporizer (Draeger,
FRG) by mechanical ventilation in 100% oxygen. This anesthetic regi-
men was chosen because it has been demonstrated not to suppress
sympathoadrenal activation produced by stress (I 1), as do some other
anesthetics, e.g., pentobarbital (12, 13).
To access the pancreatic venous blood, a laparotomy was per-
formed and an extracorporeal Silastic (Dow Corning Corp., Midland,
MI) shunt containing a sampling port and an electromagnetic flow
probe (In Vitro Metric Systems, Healdsburg, CA) was placed between
the superior pancreatic vein (SPV) and the portal vein (4). To ensure
that the NE measured in the pancreatic venous plasma was derived
solely from the pancreas, the adjacent duodenum was surgically ex-
cluded (4). The femoral artery (FA) and vein were also cannulated for
blood sampling and drug infusion.
In selected dogs, the pancreas was surgically denervated by con-
tinuing the duodenal exclusion to the level of the pyloric sphincter.
Next, all of the mesenteric attachments to the pancreas were ligated
and cut. Finally, the neural tissue surrounding the pancreatic blood
vessels was dissected free, ligated, and severed.
To determine if the rise ofNE measured in arterial plasma during
stress was of neuronal origin, or derived from the adrenal medulla, as
has been suggested by some reports (9, 10), other dogs were adrenal
deprived; they either had both adrenals surgically removed or com-
pletely isolated by ligation.
In dogs whose thoracic splanchnic nerves were electrically stimu-
lated, bilateral thoracotomies were performed at the seventh intercos-
tal space. The splanchnic nerves were dissected free from the sur-
rounding tissue along the dorsal ribcage, and bipolar electrodes (Har-
vard Apparatus Co., South Natick, MA) were placed on each nerve.
The nerves were then severed anterior to the electrodes, the thoracot-
omy incisions were sutured closed, and the pleural cavity was evacu-
ated.
In dogs in which neuroglucopenia was induced by the intracere-
broventricular administration of glucopenic glucose analogues, a cra-
nial midline incision was made and the muscles overlying the skull
were dissected free. These muscles were then retracted and a 5-mm
hole was drilled through the skull 40 mm anterior to the occipital crest
and 9 mm lateral to the midline. An 18-gauge steel cannula was then
inserted into the lateral ventricle (- 30 mm deep). At the conclusion
of the experiments, a fluorescent dye, (fluorescein isothiocyanate,
Sigma Chemical Co., St. Louis, MO) was infused into the cannula. The
dog was then killed, the brain was removed, and the placement of the
cannula in the lateral ventricle was verified by observing an extensive
staining of the cerebral ventricular system with an ultraviolet light
source.
In dogs in which 2-DG was administered locally into the pancreas,
a 22-gauge Teflon cannula (Abbott Inc., North Chicago, IL) was in-
serted into the superior pancreatic artery. Adequate perfusion of the
pancreatic tissues was verified at the conclusion of the experiments by
infusing a dye (sodium indigotindisulfonate; Hynson, Wescott, and
Dunning, Baltimore, MD) into the pancreatic arterial cannula. A sta-
bilization period of at least 60 min followed all surgical procedures
before the experiments were begun.
Protocols. Because the pancreas extracts NE from arterial plasma
(7), circulating NE makes only a small contribution to the NE mea-
sured in the pancreatic venous effluent. Therefore, to accurately cal-
culate pancreatic NE output, a measurement of pancreatic NE extrac-
tion is needed. In these experiments, tritiated NE ([3H]NE; New En-
gland Nuclear, Boston, MA) was administered intravenously as a bolus
of 30 gCi followed by an infusion of 1.3 uCi/min and the pancreatic
extraction of [3H]NE was used as an ongoing index ofthe extraction of
endogenous arterial NE. The structure of the [3H]NE was: L-Ring-
2,5,6,[3H]NE and the specific activity was 40 Ci/mmol.
To validate our method ofassessing pancreatic noradrenergic activ-
ity by measuring pancreatic NE spillover, the thoracic splanchnic
nerves were electrically stimulated (bilateral thoracic splanchnic nerve
stimulation [BTSNS]) for 10 min with square-wave pulses of 1 mS
duration and 10 mA current at a frequency of 8 Hz. The stimulations
were performed with a stimulator coupled to a stimulus isolation unit
(models S-44 and PSIU6, respectively; Grass Instrument Co., Quincy,
MA). Stimulation parameters were monitored with an oscilloscope.
Paired baseline blood samples were drawn from the FA and from the
pancreatic vein at 10 and 0 min before, at 5 and 10 min during, and at
5, 15, and 30 min after BTSNS. To determine if our technique for
severing the nerves to the pancreas produced a complete denervation,
BTSNS was repeated in dogs whose pancreata had been surgically
isolated as described above.
To determine the adrenal, systemic, and pancreatic responses to
different stresses, three stress states were tested: central neurogluco-
penia, hemorrhagic hypotension, and hypoxia.
Neuroglucopenia was induced by the intravenous infusion of2-DG
(8), (U. S. Biochemical Corp., Cleveland, OH; 600 mg-kg-' + 13.5
mg- kg-' * min-'). The long plasma half-life of 2-DG prevented the
reversal of the glucopenic stress during the time course of the experi-
ment. To determine if an increase of pancreatic NE output produced
by 2-DG was the result of extrinsic activation of pancreatic noradren-
ergic nerves or to a local effect ofglucopenia directly on nerves within
the pancreas itself, 2-DG was also administered to dogs with surgically
denervated pancreata.
Hemorrhagic hypotension was induced by rapidly removing blood
(- 20 ml/kg) from the FA until the mean arterial pressure (MAP) was
50 mmHg. MAP was maintained at 50 mmHg by further removal or
reinfusion ofblood. Hemorrhagic hypotension was reversed by rapidly
reinfusing all of the blood removed during the hypotensive period.
Hypoxia was induced by reducing the inspired oxygen concentra-
tion to 6-8% of the inspired volume by replacing the oxygen with
nitrogen. Hypoxia was reversed by reinstating the oxygen at 100% of
the inspired volume.
To determine if central glucopenia induced by the intracerebro-
ventricular injection ofglucopenic glucose analogues activates pancre-
atic noradrenergic nerves, 2,000 mg 2-DG and 200 mg 5-TG, (U. S.
Biochemical) were injected into the lateral ventricle in a volume of 6
ml of mock cerebrospinal fluid at a rate of 0.4 ml/min over 15 min.
Blood samples were drawn from the FA and from the pancreatic
vein 15, 10, 5, and 0 min before, at 5, 15, 30, 35, 40, and 45 min after
the onset of stress and 5, 15, and 30 min after the reversal of hypoten-
sion or hypoxia.
To determine if 2-DG directly activated pancreatic noradrenergic
nerves, 20-100 mg/min 2-DG was infused into the superior pancreatic
artery in saline at 0.9 ml/min for 30 min. Blood samples were drawn
from the FA and from the pancreatic vein 10 min before and at 5, 10,
20, and 30 min during the pancreatic arterial 2-DG infusion.
In all experiments, blood flow in the pancreatic venous shunt was
monitored with an electromagnetic flowmeter (Zepeda Instruments,
Seattle, WA). Hematocrit was determined at regular intervals
throughout the experiments.
Assays and data analysis. Blood samples for catecholamine deter-
minations were drawn into tubes containing EGTA and glutathione.
Samples were placed on ice until centrifugation (20 min at 4°C). The
plasma was then decanted and frozen at -20°C until assayed. Plasma
NE and EPI were measured in duplicate with a highly sensitive and
specific radioenzymatic assay (14). The intra- and interassay coeffi-
cients of variation for the plasma catecholamine assay in this labora-
tory are 6 and 12%, respectively. The concentration ofplasma 13H]NE
was determined by liquid scintillation counting of radiolabeled NE
after alumina extraction to separate NE from its metabolites (15).
The fractional extraction of [3H]NE by the pancreas was calculated
as: [3H]NEFA - [3H]NEspv/[3H]NEFA. The contribution of arterial NE
to that in pancreatic venous plasma was calculated as: [NE]FA X (I
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-fractional extraction of [3H]NE). Pancreatic NE output was calcu-
lated by the formula: {[NE]spv - (arterial contribution)} X (SPV blood
flow) X (1 -hematocrit).
The changes in arterial NE and EPI and of pancreatic NE output
during BTSNS were calculated by subtracting the mean of the two
baseline values from the mean of the 5- and 10-min values. The
changes of arterial NE and EPI and of pancreatic NE output during
stress were calculated by subtracting the mean of the four baseline
values from the mean ofthe 30-, 35-,40-, and 45-min values during the
stresses. The changes of pancreatic NE output during the pancreatic
arterial infusion of 2-DG were calculated by subtracting the mean of
the baseline sample from the mean ofthe 20- and 30-min values during
the infusion.
The data are expressed as mean±SE. Statistical comparisons of
means within a group were made with a paired t test. Statistical com-
parisons of means of different groups were made with a two-sample t
test. For multiple comparisons between more than two groups, analy-
sis of variance was performed, followed by Dunnett's test.
Results
Responses to BTSNS. In dogs with intact pancreata, BTSNS
increased arterial plasma NE levels from a baseline of 200±20
to 790±130 pg/ml (A = +600±130 pg/ml, P < 0.0025). Levels
ofNE in the pancreatic vein also increased from a baseline of
90± 10 to 880±130 pg/ml (A = +800±130 pg/ml, P < 0.0005).
The pancreatic extraction of [3H]NE was 77±2% before, and
76±3% during BTSNS. These values, together with pancreatic
venous blood flow and hematocrit, are given in Table I. Using
these data, pancreatic NE output was calculated. NE output
increased from a baseline of 160±20 to 2,310±700 pg/min
during BTSNS (A = +2,150±690 pg/min, P < 0.01, Fig. 1).
Arterial EPI also increased during BTSNS; from a baseline
of 290±40 to 1,600±360 pg/ml (A = + 1,310±400 pg/ml,
P < 0.01, data not shown).
In dogs with surgically denervated pancreata, BTSNS in-
creased arterial plasma NE from 290±50 to 1,110±150 pg/ml
(A - +820±150 pg/ml, P < 0.0005), not significantly different
than in dogs with intact pancreatic innervation. Pancreatic
venous NE levels in the pancreatic-denervated dogs increased
less than in the intact dogs; rising from 100±10 to 430±110
pg/ml (A = +330±100 pg/ml, P < 0.01). The pancreatic ex-
traction of [3HJNE and the hematocrit during BTSNS were
similar to those in the intact dogs, however, the pancreatic
venous blood flow appeared somewhat lower (Table I). In the
pancreatic-denervated dogs, baseline pancreatic NE output
was 90±10 pg/min and did not increase significantly in re-
sponse to BTSNS (A = + 110±70 pg/min, P < 0.01 vs. intact
innervation, Fig. 1). Arterial EPI increased during BTSNS in
the dogs with denervated pancreata from 460±90 pg/ml to
2,500±690 pg/ml (A = +2,040±700 pg/ml, P < 0.025), not
significantly different from the increment in intact dogs (data
not shown).
Responses to 2-DG-induced neuroglucopenia. The intrave-
nous injection of2-DG in dogs with intact pancreata increased
arterial NE from 250±40 to 640±70 pg/ml (A = +380±60
pg/ml, P < 0.0005, Table I, see also Fig. 4). Pancreatic venous
levels of NE increased to a similar degree during 2-DG (A
= +360± 100 pg/ml, Table I). Pancreatic extraction of[3H]NE
averaged 72±3% before and 71±3% during 2-DG. Pancreatic
venous blood flow and hematocrit are presented in Table I.
Thus pancreatic output of NE increased from 380±100 to
1,490±330 pg/min (A = +1,110±290 pg/min, P < 0.01) dur-
ing central glucopenia in intact dogs (Table I, Fig. 2). Arterial
EPI also increased in response to 2-DG (A = +750±170 pg/ml,
P < 0.005, Table II, see also Fig. 5). In these animals, the MAP
decreased slightly, by 15±5 mmHg and the heart rate (HR)
increased by 30±17 bpm during the glucopenia.
In dogs with denervated pancreata, arterial plasma NE in-
creased during 2-DG to a greater extent than in the intact dogs
(i.e., by 770±170 pg/ml, P < 0.005), whereas SPV NE levels
only rose by 220±40 pg/ml (P < 0.0025, Table I). The extrac-
tion of [3H]NE, SPV blood flow, and hematocrit were similar
to the corresponding values obtained in dogs with intact pan-
creata (Table I). Output of NE in dogs with denervated pan-
creata thus rose only by 120±50 pg/min during central gluco-
penia, a value only 10% of that in intact dogs (P < 0.01 vs.
intact innervation, Fig. 2). Arterial EPI increased during 2-DG
in dogs with denervated pancreata by an amount (740±200
pg/ml, P < 0.01) very similar to that in dogs with intact pan-
creata (data not shown).
In dogs infused with 2-DG and 5-TG in the lateral cerebral
ventricles, baseline arterial plasma NE increased by 710±130
pg/ml, (P < 0.005), and SPV plasma NE levels increased by
590±120 pg/ml, (P < 0.005). Pancreatic venous blood flow
and hematocrit from these dogs are shown in Table I. Thus,
pancreatic NE output increased by 850±190 pg/min, (P
< 0.01) in response to the central administration of2-DG and
5-TG, not significantly different from the response to the intra-
venous administration of2-DG (Table I).
In six dogs, 2-DG was infused locally into the superior
pancreatic artery at rates calculated to exceed systemic arterial
Table I. NE Responses to Nerve Stimulation and Stress
A NEFA A N^wv % NE ext. BFspv 1 - HCt A Pancreatic NE output
Pg/mi mil/min pg/min
BTSNS (n = 8) +600±130 +800±130 76±3 6.0±0.8 0.50±0.01 +2,150±700
BTSNS (denervated) (n = 8) +820±150 +330±100 73±2 3.4±0.5 0.50±0.02 +110±70
Neuroglucopenia (intravenous 2-DG) (n = 6) +380±60 +360±100 71±3 7.0± 1.1 0.58±0.02 +1,110±290
Neuroglucopenia (2-DG + 5-TG, ICV) (n = 5) +710±130 +590±120 75±3 4.3±0.2 -0.52±0.01 +850±190
Neuroglucopenia (denervated) (n = 6) +770±170 +220±40 72±1 8.7±1.8 0.60±0.02 +120±50
Hypotension (n = 6) +420±70 +130±80 86±2 2.7±0.5 0.56±0.01 +80±110
Hypoxia (n = 5) +590±310 +110±50 73±2 7.6±0.4 0.53±0.03 -20±60
Values are means±SE. BF, blood flow; Ext, extraction; Hct, hematocrit; ICV, intracerebroventricular.
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Figure 1. The change of pancreatic NE output in response to BTSNS
(8 Hz, 1 mS, 10 mA) in dogs with intact pancreatic innervation and
in dogs with denervated pancreata.
levels during IV 2-DG administration. This local infusion was
calculated to produce pancreatic arterial plasma 2-DG levels
of 1,580±490 mg/dl. Intravenous 2-DG administration only
produced arterial plasma 2-DG levels of 270±20 mg/dl. Pan-
creatic NE output increased only marginally during the pan-
creatic arterial 2-DG infusion (A = +50±20 pg/min, P
< 0.0025 vs. intravenous 2-DG).
In adrenal-deprived dogs, neuroglucopenia induced by in-
travenous 2-DG produced a larger increase of arterial plasma
NE than in dogs with intact adrenals (A = +950±120 pg/ml, P
< 0.005 vs. dogs with intact adrenals). Arterial EPI did not
increase in response to neuroglucopenia in the adrenal-
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Figure 2. The change of pancreatic NE output in response to 2-DG-
induced neuroglucopenia in dogs with intact pancreatic innervation
and in dogs with denervated pancreata.
deprived animals (A =-10±20 pg/ml, P < 0.005 vs. intact
adrenals, Table II).
Responses to hemorrhagic hypotension. During hemor-
rhagic hypotension in dogs with intact adrenals, arterial
plasma NE levels rose by 420±70 pg/ml (P < 0.005, Table I,
see also Fig. 4) and SPV NE levels by 130±80 pg/ml (Table I).
From these data together with pancreatic extraction of
[3H]NE, blood flow, and hematocrit (Table I), pancreatic NE
spillover was calculated and found to remain unchanged (A
= +80±1 10 pg/min, Fig. 3). Pancreatic vein blood flow de-
creased significantly during hemorrhagic hypotension (A
=
-3.0±0.5 ml/min, P < 0.0005), resulting in a greater degree
ofNE extraction by the pancreas (Table I). Arterial EPI levels
increased markedly during hypotension in dogs with intact
adrenals (A = +1,620±5 10 pg/ml, P < 0.025, see also Fig. 5,
Table II). The decrease ofMAP during hypotension averaged
-51±3 mmHg. HR increased by 21±9 bpm.
In adrenal-deprived dogs, hypotension did not influence
arterial EPI levels, but it increased arterial plasma NE by an
amount similar to that in the dogs with intact adrenals (A
- +330±110 pg/ml, P < 0.05, Table II).
Hemorrhagic hypotension produced a substantial decrease
of plasma NE clearance (A = -41±2%, P < 0.0005). It thus is
likely that increases of arterial NE observed during hemor-
rhagic hypotension overestimate increases of systemic norad-
renergic outflow. However, the whole body NE appearance
rate in both groups of hemorrhaged animals, intact and adre-
nal deprived, increased significantly (A = +210±50 ng/min, P
< 0.025 and +220±70 ng/min, P < 0.05, respectively, data not
shown), demonstrating the activation of systemic noradrener-
gic nerves. NE clearance did not decrease during either gluco-
penia or hypoxia. Plasma NE clearance and appearance rates
were measured by the isotope dilution technique (15).
Responses to hypoxia. During hypoxia, arterial NE levels
increased by 590±310 pg/ml (Fig. 4, Table I), and SPV NE
levels increased by only 110±50 pg/ml (Table I). These values,
together with extraction of [3H]NE, SPV blood flow, and he-
matocrit are shown in Table I. Thus, during hypoxia, pancre-
atic NE spillover did not change significantly (A = -20±60
pg/min, Fig. 3). Arterial EPI levels increased by 1,490±810
pg/ml during hypoxia, similar to the increments that occurred
during other stresses (Fig. 5). Neither MAP (A = + 11±9
mmHg) or HR (A = -7±8 bpm) changed significantly during
hypoxia. Hypoxia experiments were not repeated in adrenal-
deprived dogs.
Discussion
The technique developed and applied in this study to measure
pancreatic NE spillover is unique in that it provides a direct
measurement of pancreatic noradrenergic activity in situ. An
important component ofthis technique is the estimation ofthe
fractional extraction of arterial NE by the pancreas. Because
the pancreas extracts - 70% of arterial NE (7), the use of
uncorrected arteriovenous differences of NE across the pan-
creas would markedly underestimate pancreatic noradrenergic
activity. For example, during neuroglucopenia, the increase of
arterial NE actually exceeds that in the pancreatic vein. Using
arteriovenous differences alone, one could wrongly conclude
that pancreatic noradrenergic nerves were not activated. How-
ever, the extraction of [3H]NE indicates that most of the arte-
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Table 11. Comparison ofthe Adrenal Medullary and Systemic Noradrenergic Reponses to Stress in Intact and Adrenal-deprived Dogs
Neuroglucopenia
Neuroglucopenia (adrenal, deprived) Hemorrhagic hypotension Hemorrhagic hypotension
(n = 6) (n = 4) (n = 6) (adrenaldeprived)(n = 4)
A Plasma EPIFA (pg/ml) +750±170 -10±20 +1,620±510 +40±30
A Plasma NEFA (pg/ml) +380±60 +950±120 +420±70 +330±110
Values are means±SE.
rial NE never reaches the pancreatic venous plasma, and there-
fore should not be subtracted from the pancreatic venous NE
level when calculatingNE output. Esler et al. have used similar
techniques to measure organ-specific noradrenergic activity in
man (16), and have recently reviewed methods for assessing
regional sympathetic neural activity (17).
Despite the logical basis of the spillover calculations, we
sought to experimentally validate the technique by measuring
NE output from the pancreas before and during the sympa-
thetic activation produced by BTSNS in halothane-anesthe-
tized dogs with intact and surgically denervated pancreata.
BTSNS produced a rapid and large increase of pancreatic NE
output. Pancreatic NE output rapidly returned to control
levels after the period of nerve stimulation. Because the pan-
creatic NE output response was eliminated by prior surgical
denervation of the pancreas, while in both groups of dogs
BTSNS produced substantial increases ofboth arterial NE and
EPI, it seems clear that this technique provides a reliable and
specific index of the activity of noradrenergic nerves innervat-
ing the pancreas.
Having validated the technique for measuring pancreatic
NE output during BTSNS, we next sought to determine if
pancreatic noradrenergic nerves are activated during stress.
We measured pancreatic NE output and arterial plasma cate-
cholamines before and during three types of stress known to
produce sympathoadrenal activation: central neuroglucopenia
induced by intravenous 2-DG (8), hypotension induced by
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hemorrhage, and hypoxia induced by the partial replacement
of the inspired oxygen with nitrogen.
Neuroglucopenia produced a large increase of pancreatic
NE output, indicating that this stress activated pancreatic nor-
adrenergic nerves. This increase was somewhat smaller and
more delayed than the response to BTSNS. However, electrical
stimulation of both major nerve tracts might be expected to
produce near-maximal neurotransmitter release. The pancre-
atic noradrenergic activation produced by neuroglucopenia
was accompanied by a moderate increase of arterial plasma
NE. This increase was also present in adrenal-deprived ani-
mals, suggesting that nonpancreatic noradrenergic nerves are
also activated in response to neuroglucopenia. This conclusion
contrasts with that of another study, in which urinary NE
excretion in adrenalectomized rats did not increase during
neuroglucopenia (18). A large increase of arterial EPI con-
firmed adrenal medullary activation by neuroglucopenia in
this study. As expected, the arterial EPI response to neuroglu-
copenia was abolished by adrenal deprivation.
Although stress-induced activation of the noradrenergic
input to the pancreas has often been postulated (19, 20), pre-
viously there has been no direct measurement of increased
pancreatic noradrenergic activity during acute stress in vivo.
However, other studies have indirectly suggested that stress
may activate pancreatic noradrenergic nerves in vivo. Jarhult
and Holst found that unloading the carotid baroreceptors
(simulated hypotension) in adrenalectomized cats produced
2-DG
(n=6)
Hemorrhage
(n=6)
Hypoxia
(n=5)
-15 0 15 30
MINUTES
45/0 15 30 Figure 3. The change of pancreatic NE output in re-
sponse to 2-DO-induced neuroglucopenia, hemorrhagic
hypotension, and hypoxia.
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Figure 4. The change of femoral arterial NE in response to 2-DG-
induced neuroglucopenia, hemorrhagic hypotension, and hypoxia.
sympathomimetic effects on pancreatic hormone secretion
(21). Increased NE turnover also has been demonstrated in the
pancreata ofcold-exposed rats, suggesting that chronic stress of
this type may increase pancreatic noradrenergic activity (22).
Stress-induced increases of pancreatic noradrenergic activ-
ity have also been indirectly suggested through in vitro experi-
mentation. For example, the activity of intrinsic pancreatic
noradrenergic nerves apparently increases with abrupt lower-
ing ofambient glucose levels. This is inferred from reports that
the enhanced glucagon release, which results from lowering
perfusate glucose levels in isolated canine (23) or rat (24) pan-
creata, is blocked by the alpha-adrenergic antagonist, phento-
lamine. More direct evidence is provided by a report that per-
fusion of isolated canine pancreata with an extremely low-glu-
[zizSTRESS
. .~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
cose media releases large amounts of NE (25). These reports
suggest that severe local glucopenia may directly activate nor-
adrenergic nerves in the isolated pancreas in vitro. In contrast,
this study demonstrates that the activation of pancreatic nor-
adrenergic nerves by glucopenia is largely eliminated by pan-
creatic denervation. Thus, in vivo, glucopenia appears to acti-
vate a central mechanism that in turn increases the sympa-
thetic outflow to the pancreas. This conclusion is further
supported by our demonstration that central glucopenia, in-
duced by the cerebral ventricular administration ofglucopenic
agents, also increases pancreatic norepinephrine output and
that the local pancreatic administration of 2-DG does not.
In contrast to the increase of pancreatic NE output ob-
served during glucopenia, neither hypotension nor hypoxia
increased pancreatic NE output. This stress-specific activation
occurred despite similar degrees of surgical stress in all three
experiments. Therefore, it is unlikely that the presence of sur-
gical stress contributed to the specificity ofthe activation. Sur-
gical stress may contribute to the increases of systemic cate-
cholamines seen during all three stresses. However, the in-
creases of both arterial NE and EPI during hypotension and
hypoxia were similar to those observed during neurogluco-
penia. The ability of stress to activate pancreatic noradrenergic
nerves thus may depend more on the type of stress than its
intensity. These findings further suggest that there may be a
variety of sympathoadrenal responses that are centrally or-
chestrated to elicit a homeostatic response appropriate for the
type of stress.
A physiologic role for this stress-specific activation of pan-
creatic noradrenergic nerves might be inferred from the known
function of the endocrine pancreas to regulate plasma glucose
levels and the known effects of sympathetic activation on pan-
creatic hormone release. Electrical stimulation of sympathetic
nerves inhibits insulin secretion (3, 4) and stimulates glucagon
secretion (4, 5). Decreases of plasma insulin levels and in-
creased plasma glucagon levels would be expected to increase
plasma glucose levels by increasing hepatic glucose production
and reducing insulin-mediated glucose utilization (26). In-
2-DO
(n=6)
v- *Hemorrhage
(n=6)
'-Hypoxia
(n=5)
-15 0 15 30 45/0 15 30
MINUTES
Figure 5. The change of femoral arterial EPI in re-
sponse to 2-DG-induced neuroglucopenia, hemor-
rhagic hypotension, and hypoxia.
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deed, impaired insulin secretion and increased glucagon secre-
tion have been observed in some studies examining glucopenia
(27, 28). Although it is tempting to speculate that the central
activation of pancreatic noradrenergic nerves contributes to
the counterregulatory response for defending plasma glucose
during periods ofglucopenia, two cautions are indicated. First,
a role for the local pancreatic nerves in mediating these islet
hormone responses remains to be experimentally demon-
strated. Second, the NE output we measured was from the
entire right lobe of the pancreas, and not solely from the en-
docrine tissue of that lobe. Therefore, these measurements do
not necessarily reflect increased noradrenergic input to the
islets during glucopenic stress.
In addition to the concept of stress specificity of sympa-
thetic activation, the data from this study suggest a related
concept of regionally selective activation of the sympathetic
nervous system. For example, arterial NE increased during
hemorrhagic hypotension, whereas pancreatic NE output did
not. Because the increase of arterial NE observed during hy-
potension was unaffected by adrenal denervation, this increase
of NE likely reflects neuronal NE release rather than the re-
lease of NE from the adrenal medulla (9, 10). Nonpancreatic
noradrenergic nerves thus were activated by hypotension, de-
spite its failure to increase pancreatic noradrenergic activity.
Our demonstration of a differential pattern in the norad-
renergic response during hypotension (regional selectivity)
contrasts with the more traditional view that acute stresses
produce a generalized activation of the sympathetic nervous
system (29). However, other studies have also questioned the
traditional view. Young and Landsberg have demonstrated a
dissociation between tissue NE turnover and adrenal medul-
lary activation during several stress states (30). In addition, a
differential activation of the sympathetic nerves to skin or
muscle has been demonstrated during exercise or mental cal-
culation (31, 32). This study is unique, however, in suggesting
regional selectivity in the activation of the sympathetic nerves
during acute homeostatically disruptive stress.
In summary, we have directly demonstrated that neuro-
glucopenia activates pancreatic noradrenergic nerves in vivo,
whereas hemorrhagic hypotension and hypoxia do not. When
viewed with the peripheral adrenergic responses, these data
provide an important demonstration of stress-specific and re-
gionally selective activation ofthe sympathetic nervous system
in acute stress.
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